HK Midday: HSI up 1.22%; Innovator Drug Stocks Surge, Everest Medicines Soars Nearly 60%
Market Pulse·- Hong Kong stocks maintained an upward trend on August 20, with the Hang Seng Index rising 1.22% to 25807.29 points. - The innovative drug sector surged significantly driven by Moderna mRNA vaccine developments and strong interim results, while gold stocks strengthened as spot gold broke 4500 USD. - Meanwhile, internet technology stocks showed divergence, highlighted by Kuaishou dropping over 10% following weaker-than-expected financial results.HSI Up 291 pts; HSTI Up 72 pts; XIAOMI Up over 3%; WUXI BIO, WUXI APPTEC, BEIGENE, OOIL, TINGYI Hit New Highs
AASTOCKS News·- At the midday close, the Hang Seng Index rose 291 points to reach 25,786, while the Hang Seng Tech Index increased by 72 points to 4,754. - Major heavyweights such as XIAOMI, BABA, and TENCENT recorded solid gains alongside broader market movements. - Stocks including WUXI BIO, WUXI APPTEC, BEIGENE, OOIL, and TINGYI hit new highs during the trading session.HK Stocks Midday: HSI Falls Over 100 Pts; Oil Stocks Rise on Mideast Tensions; Biotech Broadly Higher
Market Pulse·- On August 18 morning, Hong Kong stock indices declined collectively, with the Hang Seng Index down 0.58 % to 25305 points. - Oil and biotech stocks bucked the trend to rise, driven by escalating Middle East tensions and strong domestic pharmaceutical export trade values. - Financial, insurance, and major technology stocks faced downward pressure amid rising 30-year US Treasury yields and overseas debt reductions.BeiGene gains 2% in Hong Kong after sharp intraday surge
HK Stock Market Update·HK Midday: Hang Seng Drops Nearly 1%, Loses 26,000; Biomed Stocks Surge, Autos Tumble
Market Pulse·- On August 11, Hong Kong stocks fluctuated weakly, with the Hang Seng Index falling 0.93% to 25697.35 points. - Biopharmaceutical and oil stocks strengthened against the market trend driven by positive catalysts and rising oil prices. - Technology and auto stocks generally declined amid market wait-and-see sentiment, high inventory pressures, and upcoming earnings and inflation data.BeiGene climbs 4% in Hong Kong trading after RAS collaboration deal
HK Stock Market Update·